For primary prevention patients at high risk, such as those with a 10-year risk > 10%, the LDL target is less than 70 mg/dL (class 2a recommendation). For this group, treatment begins with a ...
The AHA urges doctors to begin screening and treating patients who are still in their 30s, well before the risks of a heart attack and stroke are higher.
Extent of disease: Patients with 10% or less vitiligo and particularly facial or limited lesions tend to benefit most from ...
A 65-year-old white woman presented with 9 months of intermittent “kaleidoscopic” visual disturbances and blurred vision upon ...
The first multisociety guidelines on the diagnosis and management of acute pulmonary embolism feature a new classification ...
Experts examine MFN pricing, the Great Healthcare Plan, ACA subsidies, PBM reform, and CMS talks in 2026. Lindsay Bealor ...
Heart health experts released new guidance to help identify early risk factors for heart disease that go beyond tracking ...
US Food and Drug Administration Approval Summary: Ribociclib With an Aromatase Inhibitor in the Adjuvant Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Stage II and III ...
Appropriate use of immune checkpoint inhibitors and immunotherapy differs in adults with unresectable, metastatic cutaneous ...
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results